Danaher (DHR) Financials

Danaher’s latest quarter shows a mixed but generally resilient picture. In Q1 2026, revenue came in at $5.95 billion, down from $6.84 billion in Q4 2025 and slightly below the $5.74 billion reported in Q1 2025. Profitability also softened on a sequential basis, with operating income of $1.34 billion versus $1.50 billion in Q4 2025 and $1.27 billion in Q1 2025. Even so, Danaher continued to generate strong cash flow and maintained a very solid balance sheet.

Over the last four years, the company has remained highly profitable and cash-generative, but investors should note that growth has been uneven and the business has leaned on acquisitions, debt, and large non-cash amortization charges. That combination usually points to a high-quality industrial/healthcare platform, but also one with meaningful acquisition-related accounting assets on the balance sheet.

• Strong operating cash flow: Q1 2026 operating cash flow was $1.32 billion, showing Danaher can still convert earnings into cash effectively.
• Healthy profitability: Q1 2026 net income was $1.03 billion, with diluted EPS of $1.45, indicating continued earnings power.
• Solid gross margin profile: Q1 2026 gross profit was $3.59 billion on $5.95 billion of revenue, a strong level of profitability.
• Balance sheet remains large and liquid: Danaher ended Q1 2026 with $5.7 billion in cash and equivalents and $83.5 billion in total assets.
• Equity base is substantial: Total common equity was $52.9 billion in Q1 2026, providing a meaningful capital cushion.
• Cash generation covers shareholder returns: The company paid $226 million in dividends in Q1 2026 while still producing more than $1.3 billion in operating cash flow.
• Revenue trend has been choppy: Quarterly revenue has moved between roughly $5.7 billion and $6.8 billion over the past year, suggesting uneven top-line momentum.
• Heavy intangible assets and goodwill: Goodwill of $42.8 billion and intangible assets of $17.2 billion make up a large share of assets, which is typical for an acquisition-driven company but adds impairment risk.
• Debt remains material: Danaher had $923 million of short-term debt and $17.6 billion of long-term debt in Q1 2026, so leverage is still a factor to watch.
• Short-term cash fell sharply from late 2025: Cash dropped to $5.7 billion in Q1 2026 from $15.3 billion in Q3 2025, reflecting debt repayment, dividends, and investing activity.

Looking at the broader trend, Danaher’s earnings have been consistently positive from 2023 through early 2026, with quarterly net income generally ranging around $0.9 billion to $1.6 billion. Operating margins have been healthy, but they have narrowed at times when SG&A costs rose or revenue softened. The most recent quarter also showed that cost discipline will matter if top-line growth stays modest.

Cash flow has been a clear strength over time. Even in weaker quarters, Danaher has typically generated more than $1.0 billion in operating cash flow. That’s important because it supports dividends, debt service, and reinvestment. However, investing cash flow has often been negative due to capital spending and acquisitions, while financing cash flow has swung widely as the company repays or issues debt and repurchases shares.

Bottom line: Danaher still looks like a financially strong, high-quality company with excellent cash generation and a sturdy balance sheet. The main watch items are slower revenue growth, the size of acquisition-related intangible assets, and the company’s ongoing use of debt. For retail investors, this is a stock that still appears fundamentally sound, but one where future upside likely depends on reaccelerating growth and continued margin discipline.